A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Albert Assad, MD
Incyte Corporation
Study Director - Sarah Tasian, MD
Children's Hospital of Philadelphia, Philadelphia, PA
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
111 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alberta'S Children Hospital
Calgary, Alberta, Canada
- Bc Children'S Hospital
Vancouver, British Columbia, Canada
- the Hospital for Sick Children
Toronto, Ontario, Canada
- Chu Sainte-Justine
Montreal, Quebec, Canada
- Mcgill University Health Centre/glen Site/cedars Cancer Centre
Montreal, Quebec, Canada
- Mcmaster University Medical Centre
Hamilton, Canada
- University Pediatric Hospital
San Juan, PR, Puerto Rico
- San Jorge Childrens Hospital
San Juan, Puerto Rico
- the Childrens Hospital of Alabama
Birmingham, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arkansas Childrens Hospital
Little Rock, Arkansas, United States
- Kaiser Permanente
Fontana, California, United States
- Loma Linda University Cancer Center
Loma Linda, California, United States
- Miller Childrens Hospital Pharmacy
Long Beach, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Kaiser Foundation Health Plan
Los Angeles, California, United States
- Southern California Permanente Medical Group
Los Angeles, California, United States
- Valley Childrens Hospital
Madera, California, United States
- Choc Children Hospital
Orange, California, United States
- Lucille Packard Childrens Hospital
Palo Alto, California, United States
- Kaiser Permanente
San Diego, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- Ucsf Pediatric Oncology
San Francisco, California, United States
- Kaiser Permanente Downey
Santa Fe Springs, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Connecticut Children'S Medical Ctr
Hartford, Connecticut, United States
- Smilow Cancer Center - Yale
New Haven, Connecticut, United States
- Alfred I. Dupont Hospital for Children
Wilmington, Delaware, United States
- Childrens Hospital of Southwest Florida
Fort Myers, Florida, United States
- Joe Dimaggio Children Hospital
Hollywood, Florida, United States
- Nemours Childrens Clinic
Jacksonville, Florida, United States
- University of Florida Health Shands Hospital
Jacksonville, Florida, United States
- Arnold Palmer Hospital for Children
Orlando, Florida, United States
- Florida Hospital Orlando
Orlando, Florida, United States
- Nemours Childrens Clinic
Pensacola, Florida, United States
- All Childrens Hospital
St. Petersburg, Florida, United States
- St Josephs Childrens Hospital Tampa
Tampa, Florida, United States
- Saint Marys Medical Center
West Palm Beach, Florida, United States
- Egleston Children'S Health
Atlanta, Georgia, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2016
- Primary completion
- 3 Mar 2026
- Completion
- 3 Mar 2026
- Last update posted
- 11 Mar 2026
- Registered enrollment
- 171
- Registry id
- NCT02723994
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.